| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06beca94603d27d4b1e8238330c70ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7db6ce785b5ebdd38c71ed83d75bd65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba622c59078c5629f03e3d7f61af59ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a4c99eb8ccdf8f37ad90cfd2b49e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84eb953ad38bb8a388454dcac940ef3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d05b0206ec6741085902afaf5cfe6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d73fcb874e44baf0ca077e8154b3841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d8e1c719ef7e3fed8801575b70dc35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7ef26af339475234f4b5c8049218c3 |
| publicationDate |
2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10988524-B2 |
| titleOfInvention |
Modified relaxin B chain peptides and their therapeutic use |
| abstract |
Provided is a biologically active single chain Relaxin peptide having the following formula (I): Nter-X-(E)a-X10-E-G-R-E-X15-V-R-X18-X19-I-X21-X22-E-G-X25-S-X27-X28-X29-X30-R-(X32)b-(X33)c-(X34)d-NH2-Cter. Also provided is a pharmaceutical composition comprising at least one peptide of the invention, or a pharmaceutically acceptable salt or a solvate thereof. Further provided is the peptide, a pharmaceutically acceptable salt or solvate thereof, or the pharmaceutical composition for use as a medicament. |
| priorityDate |
2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |